Study protocol of the European Urban Burden of Disease Project: a health impact assessment study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
20 Jan 2022
Historique:
entrez: 21 1 2022
pubmed: 22 1 2022
medline: 16 3 2022
Statut: epublish

Résumé

Cities have long been known to be society's predominant engine of innovation and wealth creation, yet they are also hotspots of pollution and disease partly due to current urban and transport practices. The aim of the European Urban Burden of Disease project is to evaluate the health burden and its determinants related to current and future potential urban and transport planning practices and related exposures in European cities and make this evidence available for policy and decision making for healthy and sustainable futures. Drawing on an established comparative risk assessment methodology (ie, Urban and Transport Planning Health Impact Assessment) tool), in nearly 1000 European cities we will (1) quantify the health impacts of current urban and transport planning related exposures (eg, air pollution, noise, excess heat, lack of green space) (2) and evaluate the relationship between current levels of exposure, health impacts and city characteristics (eg, size, density, design, mobility) (3) rank and compare the cities based on exposure levels and the health impacts, (4) in a number of selected cities assess in-depth the linkages between urban and transport planning, environment, physical activity and health, and model the health impacts of alternative and realistic urban and transport planning scenarios, and, finally, (5) construct a healthy city index and set up an effective knowledge translation hub to generate impact in society and policy. All data to be used in the project are publicly available data and do not need ethics approval. We will request consent for personal data on opinions and views and create data agreements for those providing information on current and future urban and transport planning scenarios.For dissemination and to generate impact, we will create a knowledge translation hub with information tailored to various stakeholders.

Identifiants

pubmed: 35058262
pii: bmjopen-2021-054270
doi: 10.1136/bmjopen-2021-054270
pmc: PMC8783806
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e054270

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Lancet. 2014 Mar 1;383(9919):785-95
pubmed: 24332274
Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7301-6
pubmed: 17438298
Environ Int. 2017 Oct;107:243-257
pubmed: 28778040
BMJ. 2014 Feb 13;348:g425
pubmed: 24524928
Environ Health. 2016 Mar 08;15 Suppl 1:38
pubmed: 26960529
Environ Int. 2020 Nov;144:105998
pubmed: 33032072
Prev Med. 2015 Jul;76:103-14
pubmed: 25900805
Epidemiology. 2017 Jan;28(1):63-71
pubmed: 27525811
Int J Environ Res Public Health. 2018 Feb 22;15(2):
pubmed: 29470452
Lancet. 2014 Apr 12;383(9925):1325-1332
pubmed: 24183105
Environ Int. 2020 Jul;140:105661
pubmed: 32307209
Int J Environ Res Public Health. 2020 Feb 12;17(4):
pubmed: 32059598
BMJ. 2011 Aug 04;343:d4521
pubmed: 21816732
Environ Res. 2015 Feb;137:136-40
pubmed: 25531818
Environ Int. 2016 Jan;86:60-7
pubmed: 26540085
Environ Int. 2020 Jan;134:105132
pubmed: 31515043
Environ Int. 2018 Sep;118:78-85
pubmed: 29807292
Lancet. 2015 Jul 25;386(9991):369-75
pubmed: 26003380
Environ Int. 2020 Nov;144:106027
pubmed: 32827806
Int J Public Health. 2015 Jul;60(5):619-27
pubmed: 26024815
Lancet. 2015 Dec 5;386(10010):2287-323
pubmed: 26364544
Environ Int. 2020 Oct;143:105974
pubmed: 32703584
Eur Heart J. 2015 Oct 14;36(39):2653-61
pubmed: 26104392
Environ Int. 2020 Aug;141:105800
pubmed: 32474298
Environ Health Perspect. 2017 Jan;125(1):89-96
pubmed: 27346385
Environ Int. 2011 May;37(4):766-77
pubmed: 21419493
Environ Int. 2018 Nov;120:81-92
pubmed: 30075373
Nature. 2015 Sep 17;525(7569):367-71
pubmed: 26381985
Environ Health Perspect. 2014 May;122(5):439-46
pubmed: 24584099
Lancet. 2009 Dec 5;374(9705):1930-43
pubmed: 19942277
Int J Epidemiol. 2011 Feb;40(1):121-38
pubmed: 20630992
Environ Int. 2018 Dec;121(Pt 1):931-941
pubmed: 30347375
Environ Int. 2018 May;114:365-375
pubmed: 29602620
Environ Res. 2021 May;196:110988
pubmed: 33689819
Environ Int. 2015 Dec;85:111-9
pubmed: 26386464
Int J Environ Res Public Health. 2015 Dec 22;13(1):ijerph13010061
pubmed: 26703699
Lancet. 2016 Dec 10;388(10062):2925-2935
pubmed: 27671671
Int J Hyg Environ Health. 2021 Jun;235:113772
pubmed: 34102572
Environ Int. 2020 Mar;136:105520
pubmed: 32044176
Lancet Planet Health. 2021 Mar;5(3):e121-e134
pubmed: 33482109

Auteurs

Mark J Nieuwenhuijsen (MJ)

Barcelona Institute for Global Health, Barcelona, Spain mark.nieuwenhuijsen@isglobal.org.

Jose Barrera-Gómez (J)

Barcelona Institute for Global Health, Barcelona, Spain.

Xavier Basagaña (X)

Barcelona Institute for Global Health, Barcelona, Spain.
Pompeu Fabra University Faculty of Health and Life Sciences, Barcelona, Spain.

Marta Cirach (M)

Barcelona Institute for Global Health, Barcelona, Spain.

Carolyn Daher (C)

Barcelona Institute for Global Health, Barcelona, Spain.

Maria Foraster Pulido (MF)

Barcelona Institute for Global Health, Barcelona, Spain.
Ramon Llull University, Barcelona, Spain.

Tamara Iungman (T)

Barcelona Institute for Global Health, Barcelona, Spain.

Antonio Gasparrini (A)

London School of Hygiene & Tropical Medicine, London, UK.

Gerard Hoek (G)

IRAS, Utrecht University Faculty of Veterinary Medicine, Utrecht, Netherlands.

Kees de Hoogh (K)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
Basel University Faculty of Philosophy and Natural Sciences, Basel, Switzerland.

Sasha Khomenko (S)

Barcelona Institute for Global Health, Barcelona, Spain.

Haneen Khreis (H)

Texas A&M University System, College Station, Texas, USA.

Audrey de Nazelle (A)

Imperial College London, London, London, UK.

Ana Ramos (A)

Barcelona Institute for Global Health, Barcelona, Spain.

David Rojas-Rueda (D)

Colorado State University System, Fort Collins, Colorado, USA.

Evelise Pereira Barboza (E)

Barcelona Institute for Global Health, Barcelona, Spain.

Marko Tainio (M)

SYKE, Helsinki, Finland.
Polish Academy of Sciences, Warszawa, Poland.

Meelan Thondoo (M)

Barcelona Institute for Global Health, Barcelona, Spain.

Cathryn Tonne (C)

Barcelona Institute for Global Health, Barcelona, Spain.

James Woodcock (J)

IPH, Cambridge University, Cambridge, UK.

N Mueller (N)

Barcelona Institute for Global Health, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH